To assess the relationship between tumor angiogenesis markers and survival, a panel of immunohistochemical factors was used—VEGF, thrombospondin-1 (TSP-1, antiangiogenesis factor), CD31 (a nonspecific endothelial marker), and CD105 (a tumor-specific endothelial marker) [68]. This evidence concerns the gene THBS1 and neoplasm.